Companies
Cooper Companies (The)
S&P 500Health Care· USA

COO

Status-Quo-Player

Cooper Companies (The)

$71.70

+0.67%

Open $70.74·Prev $71.22

as of 13 Apr

STATUS-QUO-PLAYER

Power Core

Cooper's moat is the prescribing behavior of eye care professionals, which creates a demand-side lock-in that operates upstream of the consumer and insulates the company from direct-to-consumer disruption.

Published1 Apr 2026
UniverseS&P 500
SectorHealth Care

Direction of Movement

Upward on Share Gains, Myopia, and Integration Maturation

ROC 200

+0.6%

Referenced in 1 other analysis

Company Profile

The Cooper Companies, Inc. is a global medical device company operating through two primary segments: CooperVision and CooperSurgical. CooperVision specializes in vision care, offering a comprehensive portfolio of contact lenses including spherical, multifocal, toric, and specialty lenses under brands such as Proclear, Biofinity, MyDay, and Clariti. It serves contact lens wearers worldwide with high-quality products and practitioner support, maintaining a significant presence in the contact lens market. CooperSurgical focuses on reproductive health, fertility, and women's care, providing a broad range of medical devices that cover the entire IVF cycle, along with products like Paragard, the only hormone-free IUD available in the US. The company advances health outcomes for women, babies, and families through its diversified offerings in medical devices, fertility, and genomics. Founded in 1958 and headquartered in San Ramon, California, The Cooper Companies, Inc. plays a key role in the healthcare sector, particularly in eyecare and reproductive medicine.

Sector

Healthcare

Industry

Medical Instruments & Supplies

Employees

15,000

This page is for informational purposes only and does not constitute investment advice. L17X Research is an independent research service.